Effect of Peptide Receptor Radionuclide Therapy on Somatostatin Receptor Status and Glucose Metabolism in Neuroendocrine Tumors: Intraindividual Comparison of Ga-68 DOTANOC PET/CT and F-18 FDG PET/CT

Table 1

Demographics and clinical characteristics.

Characteristics	No.
Age
Mean ± SD	58.7 ± 12.2
Sex, 𝑛 (%)
Male	16 (64%)
Female	9 (36%)
Pathology
GEP-NET	18
CUP	2
Carcinoid	4
Pheochromocytoma	1
Number of PRRT
1	17
up to 3	8

GEP-NET: gastroenteropancreatic neuroendocrine tumor.